A heavily pre-treated adenocarcinoma patient with EGFR exon 20 insertion mutation responded to pembrolizumab plus nab-paclitaxel/bevacizumab: a case report
@article{APM55267, author = {Xiaojie Huang and Yan Yang and Pingli Wang and Han Han-Zhang and Liren Ding}, title = {A heavily pre-treated adenocarcinoma patient with EGFR exon 20 insertion mutation responded to pembrolizumab plus nab-paclitaxel/bevacizumab: a case report}, journal = {Annals of Palliative Medicine}, volume = {10}, number = {6}, year = {2020}, keywords = {}, abstract = {}, issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/55267} }